Search

Search Constraints

You searched for: Author/Creator Yajima, Hiroyuki

Search Results

1. Assessment of disease progression in dysferlinopathy: A 1-year cohort study. (29th January 2019)

3. Calculated body muscle mass as a useful screening marker for low skeletal muscle mass and sarcopenia in chronic liver disease. Issue 6 (6th March 2020)

4. Comparison of strength testing modalities in dysferlinopathy. Issue 2 (20th May 2022)

5. Direct‑acting antiviral treatment decreases serum undercarboxylated osteocalcin in male patients with chronic hepatitis C. Issue 5 (2022)

6. Early phase 2 trial of TAS‐205 in patients with Duchenne muscular dystrophy. Issue 2 (20th January 2020)

7. Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease. (19th October 2015)

8. Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease. (19th October 2015)

9. Hepatitis C virus‐related symptoms, but not quality of life, were improved by treatment with direct‐acting antivirals. Issue 3 (13th November 2017)